Programa de detección del alelo APOE-E4 en adultos mayores mexicanos con deterioro cognitivo

8Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

Introduction: In Mexico, the prevalence of neurocognitive disorders (NCDs) has increased in parallel with the increase in life expectancy. The E4 allele of the gene that encodes apolipoprotein E (APOE) is the main genetic risk factor for cognitive impairment. Objective: To replicate the association of APOE-E4 allele with neurocognitive impairment in a Mexican population, as well as to implement a genetic risk-detection program with the APOE-E4 allele. Method: A program was structured for the detection of APOE-E4 allele risk in different recruiting centers from the central zone of the Mexican Republic, with three stages: recruitment and selection of candidates for the detection of the risk-allele, genetic risk analysis and delivery of results. Results: In the genetic-association study to replicate the association with neurocognitive disorders by means of multivariate logistic models, the APOE-E4 allele increased the risk for cognitive impairment in the Mexican populations by approximately 6 % (OR: 5.83, p = 0.0025). In addition, 367 genetic risk results were delivered. Conclusions: The present program is the first one to be implemented in Mexico with the purpose to inform on a genetic risk factor for neurocognitive disorders in several centers of the country.

Cite

CITATION STYLE

APA

Genis-Mendoza, A. D., Martínez-Magaña, J. J., Bojórquez, C., Téllez-Martínez, J. A., Jiménez-Genchi, J., Roche, A., … Martínez-Hernández, A. G. (2018). Programa de detección del alelo APOE-E4 en adultos mayores mexicanos con deterioro cognitivo. Gaceta Medica de Mexico, 154(5), 555–560. https://doi.org/10.24875/GMM.18003784

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free